Coenen Named As New Medaxes Chief
Tributes Paid Following Passing Of Former Leader Joris Van Assche
Medaxes has named Jasmien Coenen as the new managing director of the Belgian off-patent industry association, following the recent passing of former leader Joris Van Assche.
You may also be interested in...
A busy October will include planned biosimilar launches and key appointments for the off-patent sector.
Increased uptake for generics and biosimilars must become Belgium’s “new normal” in the wake of the coronavirus crisis, local off-patent industry association Medaxes has argued.
With multiple Humira biosimilars slated for launch in the US next year, some simultaneously, a Vizient survey provides some insights into what could be the most important differentiating aspects. Generics Bulletin speaks to Steven Lucio, Vizient senior principal of pharmacy solutions, about the findings.